Novel clinical manifestations and treatment of hereditary apoA-I amyloidosis: when a good protein turns bad

Kidney Int. 2020 Jul;98(1):62-64. doi: 10.1016/j.kint.2020.03.030.

Abstract

Amyloidoses are life-threatening diseases caused by the deposition of various proteins including apolipoprotein A-I, the major protein of plasma high-density lipoprotein. Timely diagnostics of amyloidoses are crucial for their treatment. Colombat et al. reported novel aspects of the hereditary apolipoprotein A-I amyloidosis, including its unexpected clinical presentation and genetic origins, as well as life- and vision-saving hepatorenal transplantation. This study improves the diagnostics of apolipoprotein A-I amyloidosis, optimizes its treatment, and expands our understanding of the molecular basis of this multipronged disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amyloidosis* / diagnosis
  • Amyloidosis* / genetics
  • Amyloidosis* / therapy
  • Amyloidosis, Familial* / diagnosis
  • Amyloidosis, Familial* / genetics
  • Amyloidosis, Familial* / therapy
  • Apolipoprotein A-I / genetics
  • Humans
  • Lipoproteins, HDL

Substances

  • Apolipoprotein A-I
  • Lipoproteins, HDL